The use of monovalent or bivalent IBV vaccines significantly reduces clinical signs but not viral load after heterologous challenge
Published: January 7, 2021
Related topics
Authors:
University of Georgia
University of Georgia
University of Georgia
3 de marzo de 2020
Thanks for updating us
Would you like to discuss another topic? Create a new post to engage with experts in the community.